—EU extends review of Bayer-Monsanto “” The European Commission has extended its initial review of Bayer’s planned $66 billion acquisition of Monsanto by two weeks, to Aug. 22. The review is to evaluate the impact of the planned acquisition on the European agricultural chemicals market. Bayer has already agreed with the commission that it will sell major assets to clear the way for the acquisition. Bayer says its acquisition remains on track to be completed by year-end. /articles/95/i32/EU-extends-review-Bayer-Monsanto.html 20170807 Concentrates 95 32 /magazine/95/09532.html EU extends review of Bayer-Monsanto mergers & acquisitions, Monsanto, Bayer, agchem con bus Alex Scott business EU extends review of Bayer-Monsanto Chemical & Engineering News EU extends review of Bayer-Monsanto EU extends review of Bayer-Monsanto
by Alex Scott | August 07, 2017
—Hikma Eyes Morocco With Acquisition “” Hikma Pharmaceuticals has acquired 63.9% of Société de Promotion Pharmaceutique du Maghreb (Promopharm) for $112.2 million and is launching a tender offer for the rest of the firm. London-based Hikma says Promopharm is the ninth-largest drugmaker in Morocco, with a 3.5% market share.
by Michael McCoy | October 10, 2011
—China Sets Conditions On Lucite Acquisition “” Japan's Mitsubishi Rayon has cleared regulatory hurdles to its proposed $1.6 billion acquisition of Lucite International (C&EN, Nov. 17, 2008, page 8). The deal will create the world's largest producer of methyl methacrylate (MMA), used to make acrylic plastics.
by Jean-François Tremblay | May 04, 2009
—Oterra eyes another food-coloring acquisition “ ” The natural food-coloring company Oterra is in talks to purchase the natural pigments business of Diana Food, a subsidiary of the flavor and fragrance firm Symrise. Diana Food extracts colorful compounds from plant sources such as beets, carrots, and spirulina using a water-based process.
by Craig Bettenhausen | June 26, 2021
—LyondellBasell dawdles on Braskem acquisition “Petrochemical maker says it would still benefit from merger with its Brazilian rival” Despite long delays, LyondellBasell Industries says it continues to pursue the possible purchase of a controlling stake in Brazilian petrochemical maker Braskem. Lyondell announced last June that it was in discussions to buy the stake from Odebrecht, a Brazilian conglomerate that owns a 50.1% interest in Braskem.
by Alex Tullo | February 06, 2019
—Acquisitions Bristol-Myers Squibb will acquire small-molecule drug firm Amira “” To increase its activities in fibrotic diseases, Bristol-Myers Squibb will pay up to $475 million for the privately held biotech firm Amira Pharmaceuticals. The deal adds several compounds to the BMS pipeline: AM152, poised to enter Phase II trials to treat idiopathic pulmonary fibrosis (IPF) and scleroderma; AM211, in Phase I trials to treat asthma; and an autotaxin inhibitor in preclinical studies to treat pain and cancer metastases.
by Lisa M. Jarvis | August 01, 2011
—Carbon fiber composites drive Sekisui acquisition “Company is the latest from Japan to expand in aerospace and automotive components” Japan’s Sekisui Chemical has inked a deal to acquire Renton, Washington–based Aim Aerospace for $510 million from the private equity firm Liberty Hall Capital Partners. The acquisition will give Sekisui, a thermoplastic materials maker, access to carbon fiber–reinforced composite technology. It follows similar moves by other Japanese chemical makers that see a burgeoning future in the composite-part market. With 1,100 employees, Aim fabricates structural components, ducting, and engine casings for aerospace customers including Boeing and General Electric.
by Marc Reisch | June 20, 2019
—Thermo Fisher to buy electron microscopy supplies maker Gatan “Acquisition builds on recent purchases of electron microscope makers FEI and Phenom-World” Thermo Fisher Scientific has reached an agreement to purchase electron microscopy supplies maker Gatan from parent Roper Technologies for $925 million.
by Marc S. Reisch | July 09, 2018